Cargando…
International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases
Rare diseases, which affect over 350 million people worldwide and frequently go undiagnosed or misdiagnosed for years, suffer from sparse and dispersed medical knowledge leading to even rarer approved and effective therapeutic options for patients. A vast, unmet need for research and investment to a...
Autores principales: | Boycott, Kym M, Lau, Lilian PL, Cutillo, Christine M, Austin, Christopher P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505568/ https://www.ncbi.nlm.nih.gov/pubmed/30979709 http://dx.doi.org/10.15252/emmm.201910486 |
Ejemplares similares
-
Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective
por: Dawkins, Hugh J.S., et al.
Publicado: (2017) -
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact
por: Lochmüller, Hanns, et al.
Publicado: (2017) -
‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases
por: Lochmüller, Hanns, et al.
Publicado: (2017) -
The importance of international collaboration for rare diseases research: a European perspective
por: Julkowska, D, et al.
Publicado: (2017) -
Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective
por: Austin, Christopher P., et al.
Publicado: (2017)